Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Domenica Pellegrini"'
Autor:
Andrea Michelotti, M.G. Sarobba, Antonino Astone, Teresa Gamucci, Lucia Mentuccia, Laura Pizzuti, Paolo Marchetti, Alessandra Cassano, Emanuela Magnolfi, Antonio Giordano, Luigi Di Lauro, Isabella Sperduti, Cecilia Nisticò, Patrizia Vici, Domenico Sergi, Marcello Maugeri-Saccà, Maddalena Barba, Simonetta Buglioni, Luca Moscetti, F. Angelini, Claudia De Angelis, Arianna Pellegrino, Ernesto Rossi, Valentina Sini, I. Bertolini, Domenica Pellegrini, Clara Natoli, Michela Palleschi, Antonino Grassadonia, A. Vaccaro, Alessandra Fabi
Publikováno v:
Journal of Cellular Physiology. 232:1571-1578
Bevacizumab in combination with taxanes in HER2-negative metastatic breast cancer (MBC) patients has shown improved progression-free survival (PFS), despite the lack of clear overall survival (OS) benefit. We performed a retrospective analysis to eva
Autor:
Francesco Cognetti, Antonello Vidiri, Alessandra Fabi, Domenica Pellegrini, Gianluigi Ferretti, Simona Gasparro, Michelangelo Russillo
Publikováno v:
In vivo (Athens, Greece). 32(4)
This is a case report of a 40-year-old woman who, after conservative breast cancer treatment, developed a HER2 positive solitary brain metastasis in the left temporal lobe, without extracranial --zdisease. She underwent surgery resection followed by
Autor:
Virginia Ferraresi, Francesco Cognetti, V. Anelli, Sabrina Vari, M.G. Petrongari, Renato Covello, Carmine Zoccali, L. Favale, M. Anza, E. Checcucci, Roberto Biagini, Nicola Salducca, W. Faltyn, Domenica Pellegrini, M. Zeuli, Diana Giannarelli, Gabriella Maggi, A. Annovazzi, J. Baldi, A. Latini
Publikováno v:
Annals of Oncology. 29:viii593
Autor:
Marta Maschio, Alessandra Fabi, Diana Giannarelli, Mariantonia Carosi, Michelangelo Russillo, Maria Alessandra Mirri, Domenica Pellegrini, Giulio Metro, Andrea Pace, Carmine M. Carapella, Antonello Vidiri, Alfredo Pompili, Francesco Cognetti
Publikováno v:
Cancer Chemotherapy and Pharmacology. 65:391-397
In order to evaluate the activity of gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme (GBM), a prospective single-center phase II study was conducted.Eligible patients were required to have histologically proven GBM with eva
Autor:
Gridelli C., Gallo C., Morabito A., Iaffaioli R. V., Favaretto A., Isa L., Barbera S., Gamucci T., Ceribelli A., Filipazzi V., Maione P., Rossi A., Barletta E., Signoriello S., De Maio E., Piccirillo M. C., Di Maio M., Rocco G., Vecchione A., Perrone F., Cesare Gridelli, Paolo Maione, Antonio Rossi, Ciro Gallo, Giuseppe Signoriello, Paolo Chiodini, Simona Signoriello, Francesco Perrone, Massimo Di Maio, Maria Carmela Piccirillo, Ermelinda De Maio, Jane Bryce, Alessandro Morabito, Raffaele Costanzo, Gaetano Rocco, Rosario Vincenzo Iaffaioli, Emiddio Barletta, Roberta Formato, Aldo Vecchione, Adolfo Favaretto, Giulia Pasello, Cristina Magro, Luciano Isa, Raffaele Venezia, Mario Comandè, Santi Barbera, Francesco Renda, Antonio Volpintesta, Teresa Gamucci, Maria Anna Giampaolo, Giovanni Mansueto, Anna Ceribelli, Ilaria Carbone, Domenica Pellegrini, Virginio Filipazzi, Elena Piazza, Sabrina Ferrario, Vittorina Zagonel, Giuditta di Isernia, Marco Ciaparrone, Francovito Piantedosi, Fabiana Vitiello, Nicolò Borsellino, Maria Elia Vitale, Luigi Brancaccio, Sergio Spina, Maria Rosaria Valerio, Raffaella Felletti, Salvatore Tafuto, Marianna Giampaglia, Rita Migliorino, Francesco Rosetti, Francesco Carrozza, Nestore Rossi, Mario Spatafora, Manlio Mencoboni, Ernest Marshall
Introduction: Treatment of elderly patients with small cell lung cancer (SCLC) is based on scanty evidence. Methods: Patients with extensive SCLC, age >70 years, and performance status 0-2 were eligible for a study looking for optimal two-drug combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c287ad1d0d718db86daca9f97723eed4
http://hdl.handle.net/2318/150674
http://hdl.handle.net/2318/150674
Autor:
Piero Marchetti, Elisa Rossi, Domenica Pellegrini, G. Sarobba, D. Nicoletta, M.T. Scognamiglio, L. Pizzuti, Valentina Sini, Teresa Gamucci, G. Jamara, Isabella Sperduti, Andrea Michelotti, A. Fabi, Lucia Mentuccia, Patrizia Vici, Alessandra Cassano, A. Vaccaro, F. Ciancola, Luca Moscetti, Michela Palleschi, Arianna Pellegrino
Publikováno v:
ResearcherID
Publikováno v:
Anticancer research. 27(2)
Toxic epidermal necrolysis (TEN) is a severe mucocutaneous syndrome that can be occasionally caused by anticonvulsant drugs. In some cases, cranial irradiation may act as a precipitating factor. Thus, in cancer patients who suffer from brain metastas
Autor:
Laura Pizzuti, Paolo Marchetti, Ernesto Rossi, Jamara Giampietro, Maria Teresa Scognamiglio, Valentina Sini, Maria Giuseppa Sarobba, A. Vaccaro, Patrizia Vici, Alessandra Cassano, Michela Palleschi, Dario Nicoletta, Andrea Michelotti, Alessandra Fabi, Arianna Pellegrino, Luca Moscetti, Lucia Mentuccia, Isabella Sperduti, Domenica Pellegrini, Teresa Gamucci
Publikováno v:
ResearcherID
549 Background: Bevacizumab (B) combined with paclitaxel (P) is a treatment option in MBC patients (pts). This multicenter observational study was performed in order to evaluate activity of both B-...
Autor:
Gianluigi Ferretti, Francesco Cognetti, Giulio Metro, Paola Papaldo, A. Fabi, M. Introna, Michelangelo Russillo, Domenica Pellegrini, Alessandra Felici
Publikováno v:
Journal of Clinical Oncology. 28:1108-1108
1108 Background: In the Lapatinib Expanded Access Program (LEAP) the eligibility criteria and the dose of given drugs resembled that used in the phase III EGF 100151 study, with the exception that patients (pts) previously exposed to capecitabine and